483
Yabao Pharmaceutical Co., Ltd. BeijingFDA 483 - Yabao Pharmaceutical Co., Ltd. Beijing - April 20, 2022
Record Details
An FDA inspection of Yabao Pharmaceutical Co., Ltd. in Beijing, P. R. China, revealed significant deficiencies in equipment qualification and quality control unit procedures. The firm failed to adhere to its own written procedures for equipment calibration and performance qualification. Additionally, issues were noted in stability studies, impurity reporting, and the thoroughness of investigations into out-of-trend and abnormal data.
View Company Profile
ID · 7c6b27ac-6f09-4171-9b90-14978162dd6d
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.